Patents Assigned to CONCENTRIC ANALGESICS, INC.
  • Prodrugs of phenolic TRPV1 agonists
    Patent number: 11634384
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: April 25, 2023
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: Craig Husfeld, John F. Donovan
  • Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
    Patent number: 11464767
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: October 11, 2022
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Pegylated prodrugs of phenolic TRPV1 agonists
    Patent number: 11242325
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: February 8, 2022
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Prodrugs of phenolic TRPV1 agonists
    Patent number: 10851123
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: December 1, 2020
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: Craig Husfeld, Andrei W. Konradi
  • Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
    Patent number: 10821105
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: November 3, 2020
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Pegylated prodrugs of phenolic TRPV1 agonists
    Patent number: 10717712
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: July 21, 2020
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: John F. Donovan, Craig Husfeld
  • Prodrugs of phenolic TRPV1 agonists
    Patent number: 9359316
    Abstract: Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: June 7, 2016
    Assignee: CONCENTRIC ANALGESICS, INC.
    Inventors: Craig Husfeld, John F. Donovan